Skip to content

SILO

Silo Pharma, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.33
−4.90%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-60.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Dec 16, 2025Weisblum Eric · director, officer: Chief Executive OfficerPurchase2,500$0.42
Nov 21, 2025Weisblum Eric · director, officer: Chief Executive OfficerPurchase1,000$0.36
Nov 20, 2025Weisblum Eric · director, officer: Chief Executive OfficerPurchase4,500$0.41
Nov 20, 2025Weisblum Eric · director, officer: Chief Executive OfficerPurchase7,500$0.40
May 28, 2025Weisblum Eric · director, officer: Chief Executive OfficerPurchase10,000$0.43
May 27, 2025Linsley Wayne · directorA-Award50,000$0.43
May 27, 2025Munoz Kevin · directorA-Award50,000$0.43
May 27, 2025Ryweck Daniel E. · officer: Chief Financial OfficerA-Award50,000$0.43
May 27, 2025Weisblum Eric · director, officer: Chief Executive OfficerA-Award200,000$0.43
May 27, 2025Pavell Jeff · directorA-Award50,000$0.43
Dec 16, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase2,500$0.84
Nov 22, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase2,500$0.90
Jun 13, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase4,438$1.11
Jun 13, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase562$1.08
Apr 8, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase400$2.03
Apr 8, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase600$1.96
Apr 1, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase1,100$1.91
Apr 1, 2024Weisblum Eric · director, officer: CEO and PresidentPurchase3,408$1.94
Dec 21, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase200$1.61
Dec 21, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase500$1.63
Dec 18, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase900$1.52
Dec 18, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase200$1.50
Dec 7, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase324$1.36
Dec 7, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase76$1.34
Dec 7, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase600$1.39
Nov 30, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase1,000$1.53
Nov 27, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase250$1.78
Nov 27, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase400$1.68
Nov 22, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase300$1.56
Nov 22, 2023Weisblum Eric · director, officer: CEO and PresidentPurchase4,050$1.60
Institutional positioning

13F filings over the trailing two quarters

New 6Increased 4Reduced 3Sold out 15
FilerActionSharesFiled
ADVISORSHARES INVESTMENTS LLCIncreased663,965Apr 28, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased180,031May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased62,795May 15, 2026
JANE STREET GROUP, LLCIncreased44,763May 12, 2026
CITADEL ADVISORS LLCNew Position21,448May 15, 2026
XTX TOPCO LTDReduced17,083May 15, 2026
TWO SIGMA SECURITIES, LLCNew Position14,503May 15, 2026
VANGUARD FIDUCIARY TRUST CONew Position13,100May 8, 2026
LPL FINANCIAL LLCNew Position12,534May 6, 2026
STATE STREET CORPUnchanged12,500May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position11,221May 15, 2026
TOWER RESEARCH CAPITAL LLC (TRC)Reduced1,677May 15, 2026
IFP ADVISORS, INCNew Position175Apr 13, 2026
WELLS FARGO & COMPANY/MNUnchanged10Jul 8, 2026
CITIGROUP INCReduced1May 11, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Dec 16, 2025